Printer Friendly

Vaccinia hitched to new load.

Vaccinia hitched to new load

Vaccinia, the workhorse virus used to vaccinate against smallpox, is under investigation as a carrier of genetic material from other ogranisms. Vaccinia hybrids that produce proteins from several viruses have already proved effective in animal trials (SN: 6/15/85, p.379); now researchers from the Bethesda, Md.-based National Institutes of Health have used vaccinia to carry respiratory syncytial virus (RSV) genetic material.

RSV is a common cause of lower respiratory tract infection; in children, its effects range from mild to lethal. The researchers cloned an RSV gene that dictates the production of a glycoprotein, put the copies into vaccinia and inoculated rats with the hybrid organism. The rats produced antibodies to the glycoprotein and were able to resist RSV infection, the researchers report in the March PROCEEDING OF THE NATIONAL ACADEMY OF SCIENCES (No. 7).
COPYRIGHT 1986 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1986, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:used to carry respiratory syncytial virus
Publication:Science News
Date:Apr 12, 1986
Previous Article:Transplant drug binds to blood cells.
Next Article:Biotechnology to change farm landscape.

Related Articles
Incumbent Hall, newcomer McCown capture LCC seats.
Taking "The Movement" to MS Awareness Week March 5-11, 2007.
Start a litigation group to find strength in numbers.
New litigation groups certified at Miami convention.
Citing Merck misconduct, jurors find for plaintiff in Vioxx retrial.
More than just shoplifting.
Risk factor: throat cancer linked to virus spread by sex.
Autumn issue: Bravo.
Errors mar Autumn issue.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters